Breaking News

Melbourn Scientific Gains MIA in EU

Expands market access for inhaler test services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Melbourn Scientific has been audited by the MRHA and FDA and was recently awarded a Manufacturer’s/Importer’s Authorization (MIA) allowing it to be named as a testing and release site in the EU.   Mark Hammond, Melbourn’s chief executive officer, said, “The new license is a good endorsement of the quality of the company’s cGMP procedures and extends its capabilities. The EU is an important market and with the MIA, we are able to import commercial products that have been manufactured outsid...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters